Immunome Inc. (IMNM) has 33 open-market insider trades by 12 insiders since 2020. Over the last six months insiders net bought $104K. The most active filer is Clay B. Siegall, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Clay B. Siegall | CEOPres | — | 9 | $11.9M | 2026-07-23 |
| Michael Rapp | Dir | — | 4 | $5.3M | 2023-10-02 |
| Philip Wagenheim | Dir | — | 2 | $1.8M | 2026-03-23 |
| Jean Jacques Bienaime | Dir | — | 8 | $902K | 2026-06-05 |
| Philip Tsai | CTO | — | 3 | $711K | 2026-07-23 |
| Max Rosett | CFO | — | 1 | $460K | 2026-07-23 |
| Robert Lechleider | — | — | 1 | $300K | 2026-07-23 |
| Bruce Turner | CSO | — | 1 | $250K | 2023-10-02 |
| John L. Lamattina | Dir | — | 1 | $196K | 2023-01-15 |
| Purnanand D. Sarma | CEOPres | — | 1 | $193K | 2021-05-25 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Jack Higgins | CSO | Sell | $334K | 2026-09-11 |
| Isaac Barchas | Director | Sell | $2.2M | 2026-08-10 |
| Isaac Barchas | Director | Sell | $940K | 2026-08-06 |
| Kinney Horn | — | Sell | $2.3M | 2026-08-04 |
| Kinney Horn | — | Sell | $27K | 2026-07-07 |
| Isaac Barchas | Director | Sell | $2.4M | 2026-07-06 |
Companies that share insiders with IMNM, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Robert Lechleider | — | Sell | $1.2M | 2026-07-02 |
| Isaac Barchas | Director | Sell | $4.4M | 2026-06-30 |
| Robert Lechleider | — | Sell | $1.1M | 2026-06-25 |
| Max Rosett | CFO | Sell | $1.1M | 2026-06-15 |
| Jean Jacques Bienaime | Director | Sell | $204K | 2026-06-05 |
| Jean Jacques Bienaime | Director | Buy | $204K | 2026-06-05 |
| Jean Jacques Bienaime | Director | Buy | $104K | 2026-05-15 |
| Jack Higgins | CSO | Sell | $204K | 2026-04-02 |
| Max Rosett | CFO | Sell | $1.4M | 2026-04-02 |